Earnings Preview: Niagen Bioscience (NAGE) Q3 Earnings Expected to DeclineZacks Investment Research • Wednesday
Niagen Bioscience Launches Niagen™ Plus Liquid At-Home Injections to Support Telehealth ExpansionBusiness Wire • 10/22/26
Niagen Bioscience Makes Skincare a Permanent Tru Niagen® Category, Launching Dermatologist-Tested Niagen NanoCloud™ as a Core Tru Niagen® ProductBusiness Wire • 10/20/26
Niagen Bioscience to Report Third Quarter 2026 Financial Results on Wednesday, November 4, 2026Business Wire • 10/15/26
Andrew Shao, Ph.D., Senior Vice President of Global Regulatory and Scientific Affairs at Niagen Bioscience, Honored with the 2026 Annette Dickinson Trailblazer Award by Radicle Science and Council for Responsible Nutrition (CRN)Business Wire • 10/08/26
Niagen Bioscience Puts 25 Years of NAD+ Science Behind "Don't Get Old. Age Better.Business Wire • 10/01/26
Niagen Bioscience Announces Start-Up Agreement With Mass General Brigham (MGB) Investigators For First-Of-Its-Kind Healthy Aging Clinical TrialBusiness Wire • 09/30/26
Newly Published Preclinical Study Demonstrates CD38 as a Driver of Age-Related NAD+ Decline, Older Mothers Have Lower NAD+ Levels in Placental Tissue, and NAD+ Restoration with Nicotinamide Riboside (NR) Improves Pregnancy OutcomesBusiness Wire • 09/21/26
Niagen Bioscience Engages Veteran Pharmaceutical Executives and Biotechnology Experts to Support Drug Development Program and Strategic Business GrowthBusiness Wire • 09/17/26
Niagen Bioscience Expands Tru Niagen® Retail Footprint with GNC and Sam's ClubBusiness Wire • 08/20/26
Niagen Bioscience to Present at the 17th Annual Midwest IDEAS Investor ConferenceBusiness Wire • 08/12/26
Niagen Bioscience Launches Tru Niagen on Walmart.com, Expanding Access and Diversifying Its E-commerce Marketplace PresenceBusiness Wire • 08/06/26
Niagen Bioscience Selects Global Drug Development Pioneer Evotec to Advance Preclinical Development for NB4168Business Wire • 08/03/26
Niagen Bioscience Announces a Newly Published Analysis of Past Clinical Studies Demonstrating Niagen® (Patented Nicotinamide Riboside, NR) Supplementation Improved a Muscle-Specific Marker of Biological AgingBusiness Wire • 07/28/26
Niagen Bioscience to Present at Canaccord Genuity's 46th Annual Growth ConferenceBusiness Wire • 07/27/26
Niagen Bioscience to Report Second Quarter 2026 Financial Results on Tuesday, August 4, 2026Business Wire • 07/21/26
Niagen Bioscience Appoints Abhijit Kale, Ph.D., as Senior Director of Global External ResearchBusiness Wire • 07/16/26
Niagen Bioscience, Inc. (NAGE) Discusses Strategic Expansion Into Pharmaceutical Development and NB4168 Drug Program TranscriptSeeking Alpha • 07/15/26